nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Iloprost—PLAT—type 2 diabetes mellitus	0.00772	0.647	CrCbGaD
Bimatoprost—PTGER1—kidney—type 2 diabetes mellitus	0.00602	0.122	CbGeAlD
Bimatoprost—PTGER1—pancreas—type 2 diabetes mellitus	0.00598	0.121	CbGeAlD
Bimatoprost—PTGER3—kidney—type 2 diabetes mellitus	0.00528	0.107	CbGeAlD
Bimatoprost—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.00485	0.0984	CbGeAlD
Bimatoprost—PTGER3—adipose tissue—type 2 diabetes mellitus	0.00476	0.0966	CbGeAlD
Bimatoprost—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.0039	0.0792	CbGeAlD
Bimatoprost—PTGFR—adipose tissue—type 2 diabetes mellitus	0.00381	0.0772	CbGeAlD
Bimatoprost—AKR1C3—pancreas—type 2 diabetes mellitus	0.00341	0.0692	CbGeAlD
Bimatoprost—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.00334	0.0678	CbGeAlD
Bimatoprost—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.00309	0.0627	CbGeAlD
Bimatoprost—PTGFR—liver—type 2 diabetes mellitus	0.00267	0.0541	CbGeAlD
Bimatoprost—AKR1C3—liver—type 2 diabetes mellitus	0.00217	0.044	CbGeAlD
Bimatoprost—Dinoprostone—CYP11A1—type 2 diabetes mellitus	0.00198	0.166	CrCbGaD
Bimatoprost—Tafluprost—PTGS2—type 2 diabetes mellitus	0.0015	0.126	CrCbGaD
Bimatoprost—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000815	0.00161	CcSEcCtD
Bimatoprost—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000814	0.00161	CcSEcCtD
Bimatoprost—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000813	0.00161	CcSEcCtD
Bimatoprost—Rhinitis—Metformin—type 2 diabetes mellitus	0.000811	0.0016	CcSEcCtD
Bimatoprost—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000806	0.00159	CcSEcCtD
Bimatoprost—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000803	0.00159	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000801	0.00158	CcSEcCtD
Bimatoprost—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000801	0.00158	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000798	0.00158	CcSEcCtD
Bimatoprost—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000797	0.00158	CcSEcCtD
Bimatoprost—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000795	0.00157	CcSEcCtD
Bimatoprost—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000791	0.00157	CcSEcCtD
Bimatoprost—Pain—Sitagliptin—type 2 diabetes mellitus	0.000791	0.00156	CcSEcCtD
Bimatoprost—Asthma—Ramipril—type 2 diabetes mellitus	0.00077	0.00152	CcSEcCtD
Bimatoprost—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000765	0.00151	CcSEcCtD
Bimatoprost—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000758	0.0015	CcSEcCtD
Bimatoprost—Rash—Repaglinide—type 2 diabetes mellitus	0.000757	0.0015	CcSEcCtD
Bimatoprost—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000757	0.0015	CcSEcCtD
Bimatoprost—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000757	0.0015	CcSEcCtD
Bimatoprost—Eye disorder—Metformin—type 2 diabetes mellitus	0.000756	0.0015	CcSEcCtD
Bimatoprost—Headache—Repaglinide—type 2 diabetes mellitus	0.000753	0.00149	CcSEcCtD
Bimatoprost—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000752	0.00149	CcSEcCtD
Bimatoprost—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000751	0.00149	CcSEcCtD
Bimatoprost—Sinusitis—Losartan—type 2 diabetes mellitus	0.000751	0.00149	CcSEcCtD
Bimatoprost—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00075	0.00148	CcSEcCtD
Bimatoprost—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.00075	0.00148	CcSEcCtD
Bimatoprost—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000746	0.00148	CcSEcCtD
Bimatoprost—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000744	0.00147	CcSEcCtD
Bimatoprost—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000744	0.00147	CcSEcCtD
Bimatoprost—Bronchitis—Ramipril—type 2 diabetes mellitus	0.00074	0.00146	CcSEcCtD
Bimatoprost—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000737	0.00146	CcSEcCtD
Bimatoprost—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000736	0.00146	CcSEcCtD
Bimatoprost—Cough—Gliclazide—type 2 diabetes mellitus	0.000734	0.00145	CcSEcCtD
Bimatoprost—Angiopathy—Metformin—type 2 diabetes mellitus	0.000734	0.00145	CcSEcCtD
Bimatoprost—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000729	0.00144	CcSEcCtD
Bimatoprost—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000729	0.00144	CcSEcCtD
Bimatoprost—Dinoprostone—CYP1A2—type 2 diabetes mellitus	0.000727	0.0609	CrCbGaD
Bimatoprost—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000727	0.00144	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000722	0.00143	CcSEcCtD
Bimatoprost—Rhinitis—Losartan—type 2 diabetes mellitus	0.00072	0.00143	CcSEcCtD
Bimatoprost—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00072	0.00142	CcSEcCtD
Bimatoprost—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000717	0.00142	CcSEcCtD
Bimatoprost—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000716	0.00142	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000715	0.00142	CcSEcCtD
Bimatoprost—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000715	0.00142	CcSEcCtD
Bimatoprost—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000714	0.00141	CcSEcCtD
Bimatoprost—Nausea—Repaglinide—type 2 diabetes mellitus	0.000714	0.00141	CcSEcCtD
Bimatoprost—Asthenia—Glipizide—type 2 diabetes mellitus	0.000713	0.00141	CcSEcCtD
Bimatoprost—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000713	0.00141	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000712	0.00141	CcSEcCtD
Bimatoprost—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000711	0.00141	CcSEcCtD
Bimatoprost—Erythema—Metformin—type 2 diabetes mellitus	0.000704	0.00139	CcSEcCtD
Bimatoprost—Pruritus—Glipizide—type 2 diabetes mellitus	0.000703	0.00139	CcSEcCtD
Bimatoprost—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000701	0.00139	CcSEcCtD
Bimatoprost—Vertigo—Valsartan—type 2 diabetes mellitus	0.000695	0.00137	CcSEcCtD
Bimatoprost—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000693	0.00137	CcSEcCtD
Bimatoprost—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000688	0.00136	CcSEcCtD
Bimatoprost—Vertigo—Orlistat—type 2 diabetes mellitus	0.000686	0.00136	CcSEcCtD
Bimatoprost—Palpitations—Valsartan—type 2 diabetes mellitus	0.000683	0.00135	CcSEcCtD
Bimatoprost—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000683	0.00135	CcSEcCtD
Bimatoprost—Infection—Gliclazide—type 2 diabetes mellitus	0.000682	0.00135	CcSEcCtD
Bimatoprost—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000682	0.00135	CcSEcCtD
Bimatoprost—Palpitations—Orlistat—type 2 diabetes mellitus	0.000675	0.00134	CcSEcCtD
Bimatoprost—Cough—Valsartan—type 2 diabetes mellitus	0.000675	0.00134	CcSEcCtD
Bimatoprost—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000674	0.00133	CcSEcCtD
Bimatoprost—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000674	0.00133	CcSEcCtD
Bimatoprost—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000673	0.00133	CcSEcCtD
Bimatoprost—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000667	0.00132	CcSEcCtD
Bimatoprost—Cough—Orlistat—type 2 diabetes mellitus	0.000667	0.00132	CcSEcCtD
Bimatoprost—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000665	0.00132	CcSEcCtD
Bimatoprost—Erythema—Irbesartan—type 2 diabetes mellitus	0.000665	0.00131	CcSEcCtD
Bimatoprost—Vision blurred—Metformin—type 2 diabetes mellitus	0.000664	0.00131	CcSEcCtD
Bimatoprost—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000663	0.00131	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00066	0.00131	CcSEcCtD
Bimatoprost—Chest pain—Valsartan—type 2 diabetes mellitus	0.000658	0.0013	CcSEcCtD
Bimatoprost—Dizziness—Glipizide—type 2 diabetes mellitus	0.000657	0.0013	CcSEcCtD
Bimatoprost—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000656	0.0013	CcSEcCtD
Bimatoprost—Anxiety—Valsartan—type 2 diabetes mellitus	0.000656	0.0013	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000654	0.00129	CcSEcCtD
Bimatoprost—Tension—Irbesartan—type 2 diabetes mellitus	0.000652	0.00129	CcSEcCtD
Bimatoprost—Angiopathy—Losartan—type 2 diabetes mellitus	0.000652	0.00129	CcSEcCtD
Bimatoprost—Chest pain—Orlistat—type 2 diabetes mellitus	0.00065	0.00129	CcSEcCtD
Bimatoprost—Anxiety—Orlistat—type 2 diabetes mellitus	0.000648	0.00128	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000646	0.00128	CcSEcCtD
Bimatoprost—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000645	0.00128	CcSEcCtD
Bimatoprost—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000644	0.00127	CcSEcCtD
Bimatoprost—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000644	0.00127	CcSEcCtD
Bimatoprost—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000636	0.00126	CcSEcCtD
Bimatoprost—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00063	0.00125	CcSEcCtD
Bimatoprost—Infection—Valsartan—type 2 diabetes mellitus	0.000627	0.00124	CcSEcCtD
Bimatoprost—Rash—Glipizide—type 2 diabetes mellitus	0.000627	0.00124	CcSEcCtD
Bimatoprost—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000626	0.00124	CcSEcCtD
Bimatoprost—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000626	0.00124	CcSEcCtD
Bimatoprost—Erythema—Losartan—type 2 diabetes mellitus	0.000625	0.00124	CcSEcCtD
Bimatoprost—Headache—Glipizide—type 2 diabetes mellitus	0.000623	0.00123	CcSEcCtD
Bimatoprost—Palpitations—Metformin—type 2 diabetes mellitus	0.000622	0.00123	CcSEcCtD
Bimatoprost—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000621	0.00123	CcSEcCtD
Bimatoprost—Infection—Orlistat—type 2 diabetes mellitus	0.00062	0.00123	CcSEcCtD
Bimatoprost—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000619	0.00122	CcSEcCtD
Bimatoprost—Tension—Losartan—type 2 diabetes mellitus	0.000614	0.00121	CcSEcCtD
Bimatoprost—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000613	0.00121	CcSEcCtD
Bimatoprost—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000613	0.00121	CcSEcCtD
Bimatoprost—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000612	0.00121	CcSEcCtD
Bimatoprost—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000612	0.00121	CcSEcCtD
Bimatoprost—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000611	0.00121	CcSEcCtD
Bimatoprost—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000611	0.00121	CcSEcCtD
Bimatoprost—Hypertension—Metformin—type 2 diabetes mellitus	0.000608	0.0012	CcSEcCtD
Bimatoprost—Nervousness—Losartan—type 2 diabetes mellitus	0.000607	0.0012	CcSEcCtD
Bimatoprost—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000607	0.0012	CcSEcCtD
Bimatoprost—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000606	0.0012	CcSEcCtD
Bimatoprost—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000605	0.0012	CcSEcCtD
Bimatoprost—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000605	0.0012	CcSEcCtD
Bimatoprost—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.0006	0.00119	CcSEcCtD
Bimatoprost—Chest pain—Metformin—type 2 diabetes mellitus	0.000599	0.00119	CcSEcCtD
Bimatoprost—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000597	0.00118	CcSEcCtD
Bimatoprost—Headache—Pioglitazone—type 2 diabetes mellitus	0.000597	0.00118	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000595	0.00118	CcSEcCtD
Bimatoprost—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000594	0.00117	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000593	0.00117	CcSEcCtD
Bimatoprost—Nausea—Glipizide—type 2 diabetes mellitus	0.00059	0.00117	CcSEcCtD
Bimatoprost—Vision blurred—Losartan—type 2 diabetes mellitus	0.000589	0.00117	CcSEcCtD
Bimatoprost—Pain—Gliclazide—type 2 diabetes mellitus	0.000587	0.00116	CcSEcCtD
Bimatoprost—Rash—Glimepiride—type 2 diabetes mellitus	0.000585	0.00116	CcSEcCtD
Bimatoprost—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000584	0.00116	CcSEcCtD
Bimatoprost—Rash—Sitagliptin—type 2 diabetes mellitus	0.000583	0.00115	CcSEcCtD
Bimatoprost—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000582	0.00115	CcSEcCtD
Bimatoprost—Headache—Glimepiride—type 2 diabetes mellitus	0.000581	0.00115	CcSEcCtD
Bimatoprost—Cough—Irbesartan—type 2 diabetes mellitus	0.00058	0.00115	CcSEcCtD
Bimatoprost—Headache—Sitagliptin—type 2 diabetes mellitus	0.000579	0.00115	CcSEcCtD
Bimatoprost—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000574	0.00114	CcSEcCtD
Bimatoprost—Infection—Metformin—type 2 diabetes mellitus	0.000571	0.00113	CcSEcCtD
Bimatoprost—Insomnia—Valsartan—type 2 diabetes mellitus	0.000571	0.00113	CcSEcCtD
Bimatoprost—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000566	0.00112	CcSEcCtD
Bimatoprost—Insomnia—Orlistat—type 2 diabetes mellitus	0.000564	0.00112	CcSEcCtD
Bimatoprost—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000564	0.00112	CcSEcCtD
Bimatoprost—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000564	0.00112	CcSEcCtD
Bimatoprost—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000563	0.00111	CcSEcCtD
Bimatoprost—Vertigo—Losartan—type 2 diabetes mellitus	0.000562	0.00111	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000562	0.00111	CcSEcCtD
Bimatoprost—Somnolence—Valsartan—type 2 diabetes mellitus	0.000561	0.00111	CcSEcCtD
Bimatoprost—Skin disorder—Metformin—type 2 diabetes mellitus	0.000558	0.0011	CcSEcCtD
Bimatoprost—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000556	0.0011	CcSEcCtD
Bimatoprost—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000555	0.0011	CcSEcCtD
Bimatoprost—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000553	0.00109	CcSEcCtD
Bimatoprost—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000553	0.00109	CcSEcCtD
Bimatoprost—Palpitations—Losartan—type 2 diabetes mellitus	0.000553	0.00109	CcSEcCtD
Bimatoprost—Nausea—Glimepiride—type 2 diabetes mellitus	0.000551	0.00109	CcSEcCtD
Bimatoprost—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000549	0.00109	CcSEcCtD
Bimatoprost—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000549	0.00109	CcSEcCtD
Bimatoprost—Asthenia—Glyburide—type 2 diabetes mellitus	0.000549	0.00109	CcSEcCtD
Bimatoprost—Cough—Losartan—type 2 diabetes mellitus	0.000546	0.00108	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000545	0.00108	CcSEcCtD
Bimatoprost—Pruritus—Glyburide—type 2 diabetes mellitus	0.000541	0.00107	CcSEcCtD
Bimatoprost—Infection—Irbesartan—type 2 diabetes mellitus	0.000539	0.00107	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000538	0.00107	CcSEcCtD
Bimatoprost—Erythema—Ramipril—type 2 diabetes mellitus	0.000536	0.00106	CcSEcCtD
Bimatoprost—Pain—Orlistat—type 2 diabetes mellitus	0.000533	0.00106	CcSEcCtD
Bimatoprost—Chest pain—Losartan—type 2 diabetes mellitus	0.000532	0.00105	CcSEcCtD
Bimatoprost—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000532	0.00105	CcSEcCtD
Bimatoprost—Anxiety—Losartan—type 2 diabetes mellitus	0.000531	0.00105	CcSEcCtD
Bimatoprost—Rash—Bromocriptine—type 2 diabetes mellitus	0.000528	0.00104	CcSEcCtD
Bimatoprost—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000527	0.00104	CcSEcCtD
Bimatoprost—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000527	0.00104	CcSEcCtD
Bimatoprost—Tension—Ramipril—type 2 diabetes mellitus	0.000526	0.00104	CcSEcCtD
Bimatoprost—Headache—Bromocriptine—type 2 diabetes mellitus	0.000524	0.00104	CcSEcCtD
Bimatoprost—Nervousness—Ramipril—type 2 diabetes mellitus	0.000521	0.00103	CcSEcCtD
Bimatoprost—Dry mouth—Losartan—type 2 diabetes mellitus	0.000521	0.00103	CcSEcCtD
Bimatoprost—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000512	0.00101	CcSEcCtD
Bimatoprost—Somnolence—Metformin—type 2 diabetes mellitus	0.000511	0.00101	CcSEcCtD
Bimatoprost—Infection—Losartan—type 2 diabetes mellitus	0.000507	0.001	CcSEcCtD
Bimatoprost—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000506	0.001	CcSEcCtD
Bimatoprost—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000501	0.00099	CcSEcCtD
Bimatoprost—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000497	0.000983	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000496	0.000982	CcSEcCtD
Bimatoprost—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000493	0.000975	CcSEcCtD
Bimatoprost—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000486	0.000962	CcSEcCtD
Bimatoprost—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000484	0.000957	CcSEcCtD
Bimatoprost—Rash—Glyburide—type 2 diabetes mellitus	0.000482	0.000954	CcSEcCtD
Bimatoprost—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000482	0.000954	CcSEcCtD
Bimatoprost—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000482	0.000953	CcSEcCtD
Bimatoprost—Vertigo—Ramipril—type 2 diabetes mellitus	0.000482	0.000953	CcSEcCtD
Bimatoprost—Headache—Glyburide—type 2 diabetes mellitus	0.000479	0.000948	CcSEcCtD
Bimatoprost—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000477	0.000945	CcSEcCtD
Bimatoprost—Palpitations—Ramipril—type 2 diabetes mellitus	0.000474	0.000938	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000468	0.000926	CcSEcCtD
Bimatoprost—Cough—Ramipril—type 2 diabetes mellitus	0.000468	0.000926	CcSEcCtD
Bimatoprost—Pain—Irbesartan—type 2 diabetes mellitus	0.000464	0.000918	CcSEcCtD
Bimatoprost—Insomnia—Losartan—type 2 diabetes mellitus	0.000462	0.000913	CcSEcCtD
Bimatoprost—Chest pain—Ramipril—type 2 diabetes mellitus	0.000457	0.000903	CcSEcCtD
Bimatoprost—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000455	0.0009	CcSEcCtD
Bimatoprost—Anxiety—Ramipril—type 2 diabetes mellitus	0.000455	0.0009	CcSEcCtD
Bimatoprost—Nausea—Glyburide—type 2 diabetes mellitus	0.000454	0.000899	CcSEcCtD
Bimatoprost—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000454	0.000899	CcSEcCtD
Bimatoprost—Somnolence—Losartan—type 2 diabetes mellitus	0.000454	0.000898	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000453	0.000897	CcSEcCtD
Bimatoprost—Asthenia—Valsartan—type 2 diabetes mellitus	0.000453	0.000896	CcSEcCtD
Bimatoprost—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000449	0.000889	CcSEcCtD
Bimatoprost—Asthenia—Orlistat—type 2 diabetes mellitus	0.000447	0.000885	CcSEcCtD
Bimatoprost—Pruritus—Valsartan—type 2 diabetes mellitus	0.000446	0.000883	CcSEcCtD
Bimatoprost—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000446	0.000883	CcSEcCtD
Bimatoprost—Pruritus—Orlistat—type 2 diabetes mellitus	0.000441	0.000873	CcSEcCtD
Bimatoprost—Pain—Losartan—type 2 diabetes mellitus	0.000436	0.000864	CcSEcCtD
Bimatoprost—Rash—Gliclazide—type 2 diabetes mellitus	0.000433	0.000857	CcSEcCtD
Bimatoprost—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000433	0.000856	CcSEcCtD
Bimatoprost—Headache—Gliclazide—type 2 diabetes mellitus	0.00043	0.000851	CcSEcCtD
Bimatoprost—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000429	0.000849	CcSEcCtD
Bimatoprost—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000425	0.000841	CcSEcCtD
Bimatoprost—Dizziness—Valsartan—type 2 diabetes mellitus	0.000417	0.000826	CcSEcCtD
Bimatoprost—Dizziness—Orlistat—type 2 diabetes mellitus	0.000412	0.000816	CcSEcCtD
Bimatoprost—Asthenia—Metformin—type 2 diabetes mellitus	0.000412	0.000816	CcSEcCtD
Bimatoprost—Nausea—Gliclazide—type 2 diabetes mellitus	0.000408	0.000807	CcSEcCtD
Bimatoprost—Pruritus—Metformin—type 2 diabetes mellitus	0.000407	0.000804	CcSEcCtD
Bimatoprost—Rash—Valsartan—type 2 diabetes mellitus	0.000398	0.000787	CcSEcCtD
Bimatoprost—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000398	0.000787	CcSEcCtD
Bimatoprost—Insomnia—Ramipril—type 2 diabetes mellitus	0.000396	0.000783	CcSEcCtD
Bimatoprost—Headache—Valsartan—type 2 diabetes mellitus	0.000395	0.000782	CcSEcCtD
Bimatoprost—Rash—Orlistat—type 2 diabetes mellitus	0.000393	0.000778	CcSEcCtD
Bimatoprost—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000393	0.000777	CcSEcCtD
Bimatoprost—Headache—Orlistat—type 2 diabetes mellitus	0.000391	0.000773	CcSEcCtD
Bimatoprost—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00039	0.000772	CcSEcCtD
Bimatoprost—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000389	0.00077	CcSEcCtD
Bimatoprost—Somnolence—Ramipril—type 2 diabetes mellitus	0.000389	0.00077	CcSEcCtD
Bimatoprost—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000385	0.000762	CcSEcCtD
Bimatoprost—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000384	0.000759	CcSEcCtD
Bimatoprost—Dizziness—Metformin—type 2 diabetes mellitus	0.00038	0.000752	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000378	0.000748	CcSEcCtD
Bimatoprost—Nausea—Valsartan—type 2 diabetes mellitus	0.000375	0.000742	CcSEcCtD
Bimatoprost—Nausea—Orlistat—type 2 diabetes mellitus	0.00037	0.000733	CcSEcCtD
Bimatoprost—Asthenia—Losartan—type 2 diabetes mellitus	0.000366	0.000725	CcSEcCtD
Bimatoprost—Rash—Metformin—type 2 diabetes mellitus	0.000362	0.000717	CcSEcCtD
Bimatoprost—Dermatitis—Metformin—type 2 diabetes mellitus	0.000362	0.000716	CcSEcCtD
Bimatoprost—Pruritus—Losartan—type 2 diabetes mellitus	0.000361	0.000714	CcSEcCtD
Bimatoprost—Headache—Metformin—type 2 diabetes mellitus	0.00036	0.000712	CcSEcCtD
Bimatoprost—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000359	0.00071	CcSEcCtD
Bimatoprost—Rash—Irbesartan—type 2 diabetes mellitus	0.000342	0.000677	CcSEcCtD
Bimatoprost—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000342	0.000676	CcSEcCtD
Bimatoprost—Nausea—Metformin—type 2 diabetes mellitus	0.000341	0.000675	CcSEcCtD
Bimatoprost—Headache—Irbesartan—type 2 diabetes mellitus	0.00034	0.000672	CcSEcCtD
Bimatoprost—Dizziness—Losartan—type 2 diabetes mellitus	0.000338	0.000668	CcSEcCtD
Bimatoprost—Nausea—Irbesartan—type 2 diabetes mellitus	0.000322	0.000637	CcSEcCtD
Bimatoprost—Rash—Losartan—type 2 diabetes mellitus	0.000322	0.000637	CcSEcCtD
Bimatoprost—Dermatitis—Losartan—type 2 diabetes mellitus	0.000322	0.000636	CcSEcCtD
Bimatoprost—Headache—Losartan—type 2 diabetes mellitus	0.00032	0.000633	CcSEcCtD
Bimatoprost—Asthenia—Ramipril—type 2 diabetes mellitus	0.000314	0.000621	CcSEcCtD
Bimatoprost—Pruritus—Ramipril—type 2 diabetes mellitus	0.00031	0.000613	CcSEcCtD
Bimatoprost—Nausea—Losartan—type 2 diabetes mellitus	0.000303	0.0006	CcSEcCtD
Bimatoprost—Dizziness—Ramipril—type 2 diabetes mellitus	0.000289	0.000573	CcSEcCtD
Bimatoprost—Rash—Ramipril—type 2 diabetes mellitus	0.000276	0.000546	CcSEcCtD
Bimatoprost—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000276	0.000545	CcSEcCtD
Bimatoprost—Headache—Ramipril—type 2 diabetes mellitus	0.000274	0.000542	CcSEcCtD
Bimatoprost—Nausea—Ramipril—type 2 diabetes mellitus	0.00026	0.000514	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.29e-05	0.000214	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.22e-05	0.000213	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.21e-05	0.000213	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.17e-05	0.000211	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.13e-05	0.000211	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.13e-05	0.000211	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.04e-05	0.000209	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—LPL—type 2 diabetes mellitus	9.03e-05	0.000208	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.02e-05	0.000208	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CYBA—type 2 diabetes mellitus	9e-05	0.000208	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.96e-05	0.000207	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LPL—type 2 diabetes mellitus	8.95e-05	0.000207	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.84e-05	0.000204	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ADCY5—type 2 diabetes mellitus	8.84e-05	0.000204	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.81e-05	0.000203	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.81e-05	0.000203	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.77e-05	0.000202	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.76e-05	0.000202	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.7e-05	0.000201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.68e-05	0.0002	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.63e-05	0.000199	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GCG—type 2 diabetes mellitus	8.53e-05	0.000197	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.53e-05	0.000197	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.49e-05	0.000196	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PPP2CA—type 2 diabetes mellitus	8.47e-05	0.000195	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.45e-05	0.000195	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.4e-05	0.000194	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.39e-05	0.000194	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.36e-05	0.000193	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GCG—type 2 diabetes mellitus	8.35e-05	0.000193	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.35e-05	0.000193	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CCR5—type 2 diabetes mellitus	8.32e-05	0.000192	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.3e-05	0.000192	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GNB3—type 2 diabetes mellitus	8.3e-05	0.000192	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HMOX1—type 2 diabetes mellitus	8.26e-05	0.000191	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.25e-05	0.00019	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.21e-05	0.00019	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.19e-05	0.000189	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.19e-05	0.000189	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CAT—type 2 diabetes mellitus	8.15e-05	0.000188	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTHFR—type 2 diabetes mellitus	8.13e-05	0.000188	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—C3—type 2 diabetes mellitus	8.06e-05	0.000186	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GCG—type 2 diabetes mellitus	8.05e-05	0.000186	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.05e-05	0.000186	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.98e-05	0.000184	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.92e-05	0.000183	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOB—type 2 diabetes mellitus	7.92e-05	0.000183	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.9e-05	0.000182	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.84e-05	0.000181	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.83e-05	0.000181	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.81e-05	0.00018	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HIF1A—type 2 diabetes mellitus	7.75e-05	0.000179	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS2—type 2 diabetes mellitus	7.73e-05	0.000178	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTM1—type 2 diabetes mellitus	7.7e-05	0.000178	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.68e-05	0.000177	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.68e-05	0.000177	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.67e-05	0.000177	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.67e-05	0.000177	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AGT—type 2 diabetes mellitus	7.66e-05	0.000177	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CALM1—type 2 diabetes mellitus	7.59e-05	0.000175	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—type 2 diabetes mellitus	7.57e-05	0.000175	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—LPL—type 2 diabetes mellitus	7.56e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.53e-05	0.000174	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LEP—type 2 diabetes mellitus	7.5e-05	0.000173	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—type 2 diabetes mellitus	7.5e-05	0.000173	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOA1—type 2 diabetes mellitus	7.48e-05	0.000173	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.42e-05	0.000171	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.42e-05	0.000171	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ADCY5—type 2 diabetes mellitus	7.4e-05	0.000171	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPX1—type 2 diabetes mellitus	7.37e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.35e-05	0.00017	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.26e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AVP—type 2 diabetes mellitus	7.25e-05	0.000167	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.25e-05	0.000167	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.22e-05	0.000167	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.2e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.19e-05	0.000166	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CD36—type 2 diabetes mellitus	7.18e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.11e-05	0.000164	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.1e-05	0.000164	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.1e-05	0.000164	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPP2CA—type 2 diabetes mellitus	7.09e-05	0.000164	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.07e-05	0.000163	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.07e-05	0.000163	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS2—type 2 diabetes mellitus	7.05e-05	0.000163	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.04e-05	0.000162	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOB—type 2 diabetes mellitus	7.01e-05	0.000162	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.01e-05	0.000162	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.98e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.96e-05	0.000161	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.94e-05	0.00016	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.9e-05	0.000159	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.86e-05	0.000158	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AVP—type 2 diabetes mellitus	6.85e-05	0.000158	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.85e-05	0.000158	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.83e-05	0.000158	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.82e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MTHFR—type 2 diabetes mellitus	6.81e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.79e-05	0.000157	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.75e-05	0.000156	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS1—type 2 diabetes mellitus	6.75e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LPL—type 2 diabetes mellitus	6.69e-05	0.000154	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.69e-05	0.000154	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARA—type 2 diabetes mellitus	6.68e-05	0.000154	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOB—type 2 diabetes mellitus	6.62e-05	0.000153	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.59e-05	0.000152	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.55e-05	0.000151	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.55e-05	0.000151	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.51e-05	0.00015	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AGT—type 2 diabetes mellitus	6.47e-05	0.000149	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—INS—type 2 diabetes mellitus	6.46e-05	0.000149	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.41e-05	0.000148	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—INS—type 2 diabetes mellitus	6.41e-05	0.000148	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CALM1—type 2 diabetes mellitus	6.36e-05	0.000147	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—type 2 diabetes mellitus	6.34e-05	0.000146	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LPL—type 2 diabetes mellitus	6.32e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.31e-05	0.000146	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.28e-05	0.000145	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOA1—type 2 diabetes mellitus	6.26e-05	0.000145	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT2—type 2 diabetes mellitus	6.25e-05	0.000144	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.2e-05	0.000143	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.19e-05	0.000143	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.19e-05	0.000143	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.17e-05	0.000142	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.17e-05	0.000142	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.15e-05	0.000142	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.04e-05	0.000139	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—C3—type 2 diabetes mellitus	6.03e-05	0.000139	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—type 2 diabetes mellitus	5.94e-05	0.000137	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.93e-05	0.000137	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—C3—type 2 diabetes mellitus	5.9e-05	0.000136	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.89e-05	0.000136	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.82e-05	0.000134	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.75e-05	0.000133	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.73e-05	0.000132	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	5.73e-05	0.000132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—C3—type 2 diabetes mellitus	5.69e-05	0.000131	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3R1—type 2 diabetes mellitus	5.67e-05	0.000131	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—type 2 diabetes mellitus	5.67e-05	0.000131	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.63e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.62e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.62e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.62e-05	0.00013	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.61e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	5.61e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	5.61e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.6e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.55e-05	0.000128	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PPARG—type 2 diabetes mellitus	5.52e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.51e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.49e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.49e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.43e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.43e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.41e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—INS—type 2 diabetes mellitus	5.41e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AGT—type 2 diabetes mellitus	5.41e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.32e-05	0.000123	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—type 2 diabetes mellitus	5.3e-05	0.000122	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—type 2 diabetes mellitus	5.3e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.29e-05	0.000122	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.29e-05	0.000122	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.24e-05	0.000121	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—type 2 diabetes mellitus	5.18e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.18e-05	0.000119	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	5e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—type 2 diabetes mellitus	4.96e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.9e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.82e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—INS—type 2 diabetes mellitus	4.79e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.77e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—type 2 diabetes mellitus	4.75e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.75e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.73e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.72e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—INS—type 2 diabetes mellitus	4.69e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.64e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.63e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.62e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.61e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.54e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.53e-05	0.000105	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—INS—type 2 diabetes mellitus	4.53e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.51e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.51e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.46e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.45e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.4e-05	0.000102	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.38e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.37e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.37e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—type 2 diabetes mellitus	4.34e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.31e-05	9.94e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.2e-05	9.7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.2e-05	9.7e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SRC—type 2 diabetes mellitus	4.19e-05	9.67e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.16e-05	9.59e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.16e-05	9.59e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.11e-05	9.49e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.11e-05	9.49e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.05e-05	9.34e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.97e-05	9.16e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.97e-05	9.16e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	3.96e-05	9.13e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.87e-05	8.93e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—type 2 diabetes mellitus	3.75e-05	8.65e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.74e-05	8.62e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.72e-05	8.58e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—type 2 diabetes mellitus	3.67e-05	8.48e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.64e-05	8.41e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.6e-05	8.31e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.57e-05	8.23e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.54e-05	8.18e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.52e-05	8.13e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.49e-05	8.06e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.47e-05	8.01e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.37e-05	7.78e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.37e-05	7.78e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.34e-05	7.7e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.3e-05	7.62e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.27e-05	7.55e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.27e-05	7.53e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.2e-05	7.39e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.18e-05	7.35e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.15e-05	7.27e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	3.11e-05	7.17e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.04e-05	7.02e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.03e-05	6.99e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.96e-05	6.84e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.94e-05	6.77e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.86e-05	6.6e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—type 2 diabetes mellitus	2.82e-05	6.52e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.8e-05	6.46e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.78e-05	6.41e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.72e-05	6.29e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.72e-05	6.28e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.67e-05	6.15e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.62e-05	6.06e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	2.61e-05	6.01e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.58e-05	5.96e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.57e-05	5.94e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	2.18e-05	5.03e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	2.09e-05	4.83e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.05e-05	4.73e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.98e-05	4.56e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.93e-05	4.46e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.89e-05	4.36e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.82e-05	4.21e-05	CbGpPWpGaD
